Literature DB >> 22138000

Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery.

Mario Casolaro1, Ilaria Casolaro, Stefania Lamponi.   

Abstract

A series of vinyl hydrogels containing α-aminoacid (L-histidine, L-valine) residues was synthesized and their swelling properties evaluated at different pHs and temperatures. Unlike the zwitterionic compound containing only the l-histidine, a dual-stimuli responsiveness was improved in the carboxyl acid hydrogels carrying the l-valine residues (HVa). Besides the COOH functionality, the presence of either isopropyl and amido groups in the monomer structure renders the hydrogel also temperature-responsive, in a similar manner as the well-known poly(N-isopropylacrylamide) (pNIPAAm). The three HVa hydrogels (cross-linked with 1, 2, and 5 mol% of N,N'-ethylene-bisacrylamide, EBA) show a phase separation at the same critical pH4, although a different swelling was improved by the amount of EBA. In buffered solutions, the effect of increasing temperature led to decrease the swelling and, as the pH is close to the critical one, a further and sharper collapse of the hydrogel may be tuned. The release study of pilocarpine in physiological conditions showed a burst effect within the first few hours, followed by a sustained release for a week. The initial burst effect was strongly dependent on the kind of hydrogel investigated. As the pilocarpine is a basic molecule (pK(a)7.2), it may interact more strongly with the free carboxyl groups in the ionized state of the HVa hydrogels than the zwitterionic species of the histidine compounds. The releasing profile shows a three time greater release of the pilocarpine loaded in the HVa hydrogels. The hydrogels were found to be non-toxic against the mouse fibroblast NIH3T3 cells. The presence of pilocarpine strongly increased the cell proliferation even after 2 days.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138000     DOI: 10.1016/j.ejpb.2011.11.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

Review 1.  Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.

Authors:  Remy C Cooper; Hu Yang
Journal:  J Control Release       Date:  2019-05-22       Impact factor: 9.776

2.  Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.

Authors:  Nabil K Alruwaili; Ameeduzzafar Zafar; Syed Sarim Imam; Khalid Saad Alharbi; Nasser Hadal Alotaibi; Sultan Alshehri; Nabil A Alhakamy; Abdulaziz I Alzarea; Muhammad Afzal; Mohammed Elmowafy
Journal:  Int J Nanomedicine       Date:  2020-06-30

3.  Hydrogels for ocular drug delivery and tissue engineering.

Authors:  Marzieh Fathi; Jaleh Barar; Ayuob Aghanejad; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-12-28

4.  Norfloxacin Loaded pH Triggered Nanoparticulate in-situ Gel for Extraocular Bacterial Infections: Optimization, Ocular Irritancy and Corneal Toxicity.

Authors:  Preeti Upadhayay; Manish Kumar; Kamla Pathak
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

Review 5.  Advanced drug delivery and targeting technologies for the ocular diseases.

Authors:  Jaleh Barar; Ayuob Aghanejad; Marziyeh Fathi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-03-30

6.  Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier.

Authors:  Shuangyan Tian; Juan Li; Qi Tao; Yawen Zhao; Zhufen Lv; Fan Yang; Haoyun Duan; Yanzhong Chen; Qingjun Zhou; Dongzhi Hou
Journal:  Int J Nanomedicine       Date:  2018-01-12

Review 7.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.